Clinical Trials Directory

Trials / Unknown

UnknownNCT04085731

Driver-guided Ablation of Persistent Atrial Fibrillatiom

Driver-guided Ablation in the Treatment of Persistent Atrial Fibrillation

Status
Unknown
Phase
Study type
Observational
Enrollment
181 (estimated)
Sponsor
IRCCS Policlinico S. Donato · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, single-center, study. A targeted number of 181patients with persistent AF will be included according to pre-defined criteria. The ablation procedure consists on the identification of the arrhythmic substrate using a novel integrated mapping technique. We hypothesize that such approach may potentially lead to a mechanisms-targeted ablation strategy of persistent AF.

Detailed description

This is a prospective, single-center, study enrolling a total of 181patients with persistent AF according to well defined inclusion and exclusion criteria. The ablation procedure consists on the identification of the arrhythmic substrate using a novel integrated 3D mapping technique followed by standard CPVA at the end of the procedure. We will ablate substrates showing fast and regular electrical activities, starting from areas with the fastest mean cycle length and/or areas that have consistent rotational or focal propagation pattern and/or areas that comprise the slow conduction zone of possible arrhythmia circuits. After substrate ablation and AF termination, arrhythmia inducibility will be assessed and, if not inducible, the procedure will be completed by standard CPVA. If AF is still inducible, a new 3D map will be performed to identify further targets to be eliminated. Electrical cardioversion may be done at the end of the procedure. We hypothesized that such approach may potentially lead to a mechanisms-targeted ablation strategy leading to elimination of arrhythmic sources in individual patients, thus improving their clinical outcome. We will also characterize, identify and target the real pathophysiological substrates. After ablation, AF recurrence will be assessed by implantable loop recorder or thans-telephonic ECG recording from the end of the 3 months blanking period to 12 months following the procedure.The duration of this study is expected to be 24 months, from the first patient enrollment to the last patient follow-up.

Conditions

Interventions

TypeNameDescription
PROCEDURECatheter ablationDriver-guided catheter ablation of persistent atrial fibrillation

Timeline

Start date
2019-09-21
Primary completion
2023-09-28
Completion
2023-12-30
First posted
2019-09-11
Last updated
2023-10-02

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04085731. Inclusion in this directory is not an endorsement.